Melville, N.Y., August 7, 2001—Edward A. Blechschmidt, chairman, president and chief executive officer of Gentiva Health Services (Nasdaq: GTIV), the nation's leading provider of specialty pharmaceutical and home health care services, says Gentiva is playing a vital role in the health care continuum and that the company is positioning itself for long-term growth.
In an interview featured in the specialty pharmaceuticals issue of The Wall Street Transcript, published yesterday, Blechschmidt says that Gentiva's market leadership in the specialty pharmaceutical and home health market places, combined with the blossoming number of biopharmaceutical therapies and the growing trend toward treating many acute and chronic conditions in the home, bodes well for Gentiva's long-term growth.
In the specialty pharmaceutical marketplace, Blechschmidt believes the company has "the opportunity to expand still further on our leadership position and to be a major force in the specialty pharmaceutical marketplace, not only with specialty pharmaceutical distribution but also with new drug development and helping pharmaceutical companies commercialize new and novel drugs and certainly ones that require special handling."
In the home health care marketplace, Blechschmidt says, "we think more and more patients are going to be treated in the home, and we intend to be the leader in this growing trend of care."
Blechschmidt also believes that the range of Gentiva's specialty pharmaceutical and home health care services, combined with its national presence, means that "Gentiva plays a very vital role in the health care continuum."
The full transcript of Blechschmidt's interview with The Wall Street Transcript is available on Gentiva's Web site at: www.gentiva.com/investor/wst.htm.
Gentiva Health Services (Nasdaq: GTIV), a Fortune 1000 company, is the nation's leading provider of specialty pharmaceutical and home health care services. With more than 300 locations in the United States, the company had approximately $1.5 billion in 2000 net revenues. For more information, visit Gentiva's Web site, www.gentiva.com.
Information contained in this news release, other than historical information, should be considered forward-looking, and is subject to various risk factors and uncertainties. For instance, the company's strategies and operations involve risks of competition, changing market conditions, changes in laws and regulations affecting its industries and numerous other factors discussed in this release and in the company's filings with the Securities and Exchange Commission. Accordingly, actual results may differ materially from those anticipated in any forward-looking statements.